Abstract: The present invention relates to a liquid pharmaceutical composition for oral administration in the form of suspension which comprises the combination of ibuprofen and phenylephrine, or a pharmaceutically acceptable salt thereof, as active substances, and hypromellose, xanthan gum, liquid maltitol, glycerine and water. The composition is stable, has good organoleptical properties and shows excellent pharmacokinetic profile, providing quick absorption of the drugs. The present invention also relates to the use of the composition for treating the symptoms of flu and common cold, particularly in adults and in children over 7 years.

Abstract: The present invention relates to the combination of ibuprofen in the form of a pharmaceutically acceptable salt, and tramadol, or a pharmaceutical acceptable salt thereof, for use in the treatment of pain in humans, wherein the dosage of ibuprofen in the combination is comprised between 350 mg and 450 mg and the dosage of tramadol is comprised between 35 mg and 40 mg, expressed as equivalent weight of tramadol hydrochloride. The combination is suitable for the treatment of moderate to severe pain, of chronic or acute origin, and is particularly effective for those patients suffering from more intense pain. It also relates to a pharmaceutical composition comprising said fixed-dose combination of ibuprofen and tramadol.

Abstract: The present invention relates to montelukast for use in the treatment of erosive hand osteoarthritis. According to this use, montelukast can be administered either orally or topically, in the form of any suitable pharmaceutical composition. Patients suffering from erosive hand osteoarthritis treated with montelukast showed improvement in clinical symptoms and in radiological parameters, and also reported pain relief and hand functionality improvement.

Abstract: The present invention relates to a combination comprising cromoglicic acid or derivatives thereof and to dermatological compositions comprising said composition. The invention also relates to the use of said combination or composition for the treatment of dermatitis.

Abstract: The present invention relates to a covering that selectively absorbs visible and infrared radiation, which comprises: (a) a first anti-diffusion barrier layer (2); (b) an IR-reflecting metallic layer (3) made from at least one metallic element selected from a group comprising An, Ag, Al, Cu, Ti and Pt; (c) at least a second anti-diffusion barrier layer (4) formed by oxidation of the layer (3); (d) a structure that absorbs in the UV-VIS range, which comprises at least a first film (5) and a second film (6) made from cermet, which in turn comprises a metallic fraction made from a metal selected from Pt, Cr, Mo, W, Zr, Nb, Ta and Pd, or any alloy thereof, and a ceramic comprising an oxygen-free nitride which is constituted by a metallic oxide in which the metal is selected from aluminium, silicon and chromium; and (e) a dielectric layer that is non-reflecting in the UV-VIS range, which comprises a nitride of at least one metal selected from silicon, aluminium and chromium.